These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8769164)

  • 21. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy.
    Buturović J; Kandus A; Malovrh M; Bren A; Drinovec J
    Transplant Proc; 1990 Aug; 22(4):1726-7. PubMed ID: 2389443
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM; DeMattos A; Meyer MM; Andoh T; Barry JM
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemolytic and uremic syndrome after heart transplantation.
    Mercadal L; Petitclerc T; Assogba U; Beaufils H; Deray G
    Am J Nephrol; 2000; 20(5):418-20. PubMed ID: 11093002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine-induced renal dysfunction.
    Paul LC; de Fijter JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):224S-228S. PubMed ID: 15041342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine-triggered hemolytic-uremic syndrome in kidney graft recipients: a series of 12 cases.
    Bren AF; Kandus A; Lindic J; Kovac D; Buturović J; Vizjak A; Ferluga D
    Transplant Proc; 2001; 33(7-8):3691-2. PubMed ID: 11750572
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura in a patient with Behçet's disease treated with cyclosporin.
    Docci D; Baldrati L; Capponcini C; Facchini F; Giudicissi A; Feletti C
    Nephron; 1997; 75(3):356-7. PubMed ID: 9069461
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction.
    Kohli HS; Sud K; Jha V; Gupta KL; Minz M; Joshi K; Sakhuja V
    Nephrol Dial Transplant; 1998 Nov; 13(11):2940-2. PubMed ID: 9829509
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephrotoxic aspects of cyclosporine.
    Cattaneo D; Perico N; Gaspari F; Remuzzi G
    Transplant Proc; 2004 Mar; 36(2 Suppl):234S-239S. PubMed ID: 15041344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine A toxicity is associated with reduced endothelin immunoreactivity in renal endothelium.
    Watschinger B; Ulrich W; Vychytil A; Traindl O; Seidl S; Kainz H; Klauser R; Wamser P; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2618-9. PubMed ID: 1465886
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
    Morozumi K; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404
    [No Abstract]   [Full Text] [Related]  

  • 32. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A; Christensen H; Hartmann A; Berg KJ
    Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal function outcome in pediatric liver transplant recipients.
    Mention K; Lahoche-Manucci A; Bonnevalle M; Pruvot FR; Declerck N; Foulard M; Gottrand F
    Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcome of renal transplantation in 34 cases of childhood hemolytic-uremic syndrome and the role of cyclosporine.
    Gagnadoux MF; Habib R; Broyer M
    Transplant Proc; 1994 Feb; 26(1):269-70. PubMed ID: 8108972
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients.
    Kamar N; Allard J; Ader JL; Rostaing L
    Transplant Proc; 2004 Mar; 36(2 Suppl):248S-250S. PubMed ID: 15041347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of chronic cyclosporine nephropathy on outcome of renal allografts.
    Takeda A; Morozumi K; Haba T; Katayama A; Tominaga Y; Uchida K
    Transplant Proc; 2001; 33(7-8):3379-80. PubMed ID: 11750445
    [No Abstract]   [Full Text] [Related]  

  • 40. Theophylline for acute renal vasoconstriction associated with tacrolimus: a new indication for an old therapeutic agent?
    Thomas NJ; Carcillo JA
    Pediatr Crit Care Med; 2003 Jul; 4(3):392-3. PubMed ID: 12840610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.